Cargando…

ANTIBIOTIC SUSCEPTIBILITY PATTERNS OF DIFFERENT BACTERIA ISOLATED FROM PATIENTS WITH VENTILATOR ASSOCIATED PNEUMONIA (VAP)

OBJECTIVE: Ventilator associated pneumonia (VAP) is a frequent complication of mechanical ventilation (MV) and it is a leading cause of death in MV patients. The development of VAP has been demonstrated as being due to aspiration of oropharyngeal secretion, ventilator tubing condensate, or gastric c...

Descripción completa

Detalles Bibliográficos
Autor principal:	Alqurashi, Abdulrahman M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2005
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3410109/ https://www.ncbi.nlm.nih.gov/pubmed/23012092

Ejemplares similares

Use of a ventilator-associated pneumonia (VAP) bundle to decrease the VAP rate in Syria
por: Alsadat, R, et al.
Publicado: (2012)

The effect of lactulose in prevention of ventilator associated pneumonia (VAP)
por: Zvonicek, V, et al.
Publicado: (2001)

Surveillance tracheal aspirate in ventilator associated pneumonia (VAP)
por: Lampati, L, et al.
Publicado: (2001)

Study of microbiological and antibiotic sensitivity pattern of ventilator associated pneumonia (VAP) in ICU of a tertiary care hospital in Nepal
por: Mishra, Deebya R., et al.
Publicado: (2020)

Epidemiology of ventilator associated pneumonia (vap) in patients with abdominal sepsis
por: Hom Choudhuri, A, et al.
Publicado: (2015)

The zero-VAP sophistry and controversies surrounding prevention of ventilator-associated pneumonia
por: Colombo, Sebastiano Maria, et al.
Publicado: (2019)

Causative bacteria of ventilator-associated pneumonia in intensive care unit in Bahrain: Prevalence and antibiotics susceptibility pattern
por: Hassan, Mohamed Eliwa, et al.
Publicado: (2023)

The influence of enteral feeding on ventilator associated pneumonia (VAP) in trauma mechanically ventilated patients in ICU
por: Djazmati, W, et al.
Publicado: (2001)

Use of Adaptive Support Ventilation (ASV) in Ventilator Associated Pneumonia (VAP) - A Case Report
por: Kath, Bipphy, et al.
Publicado: (2009)

Microbiological study of ventilator-associated pneumonia (VAP) after implantation of pneumonia program zero (NZ)
por: Fernández Fernández, R, et al.
Publicado: (2015)

Use of ventilator associated pneumonia bundle and statistical process control chart to decrease VAP rate in Syria
por: Alsadat, Reem, et al.
Publicado: (2012)

354. A Comparison of Different Strategies for Optimizing the Selection of Empiric Antibiotic Therapy for Hospital-Acquired Pneumonia (HAP) and Ventilator-Associated Pneumonia (VAP) Caused by Gram-Negative Bacteria in Intensive Care Units (ICU)
por: Wangchinda, Walaiporn, et al.
Publicado: (2023)

Pneumonia associated with mechanical ventilation (VAP): influence on morbidity and mortality in critically ill patients
por: Lucena, JG, et al.
Publicado: (2001)

Non-infectious approach to ventilator-associated pneumonia (VAP) in neonates: a new concept
por: Bejeh Mir, Karim Poorsattar, et al.
Publicado: (2012)

Above and beyond: biofilm and the ongoing search for strategies to reduce ventilator-associated pneumonia (VAP)
por: Sakano, Takashi, et al.
Publicado: (2020)

Reducing antibiotic treatment duration for ventilator-associated pneumonia (REGARD-VAP): a trial protocol for a randomised clinical trial
por: Mo, Yin, et al.
Publicado: (2021)

How healthcare must respond to ventilator-associated pneumonia (VAP) in invasively mechanically ventilated COVID-19 patients
por: Szarpak, Lukasz, et al.
Publicado: (2021)

Diagnosis of Ventilator-Associated Respiratory Infections (VARI): Microbiologic Clues for Tracheobronchitis (VAT) and Pneumonia (VAP)
por: Craven, Donald E., et al.
Publicado: (2011)

Effect of Gram Stain–Guided Initial Antibiotic Therapy on Clinical Response in Patients With Ventilator-Associated Pneumonia: The GRACE-VAP Randomized Clinical Trial
por: Yoshimura, Jumpei, et al.
Publicado: (2022)

Evolution ventilator associated pneumonia (VAP) in our intensive care unit, after pneumonia zero (PZ) program implementation
por: Fernández Fernández, R, et al.
Publicado: (2015)

Treatment of ventilator-associated pneumonia (VAP) caused by Acinetobacter: results of prospective and multicenter ID-IRI study
por: Erdem, Hakan, et al.
Publicado: (2019)

Microbial etiologies of ventilator-associated pneumonia (VAP) in intensive care unit of Beni-Suef University’s Hospital
por: Maebed, Al Zahraa M., et al.
Publicado: (2021)

The Impact of Care Bundles on Ventilator-Associated Pneumonia (VAP) Prevention in Adult ICUs: A Systematic Review
por: Mastrogianni, Maria, et al.
Publicado: (2023)

1233 A Comparison of National Healthcare Safety Network (NHSN) Ventilator Associated Pneumonia (VAP) and Ventilator Associated Event (VAE) Definitions
por: Mcmullen, Kathleen, et al.
Publicado: (2014)

GRam stain-guided Antibiotics ChoicE for Ventilator-Associated Pneumonia (GRACE-VAP) trial: rationale and study protocol for a randomised controlled trial
por: Yoshimura, Jumpei, et al.
Publicado: (2018)

Prognostic differences between VAP from Acinetobacter baumanii and VAP from other microorganisms
por: Di Bonito, Marianna, et al.
Publicado: (2012)

Reducing ventilator-associated pneumonia in neonatal intensive care unit using “VAP prevention Bundle”: a cohort study
por: Azab, Seham F. A., et al.
Publicado: (2015)

Multiple cross displacement amplification-a more applicable technique in detecting Pseudomonas aeruginosa of ventilator-associated pneumonia (VAP)
por: Wang, Juxiang, et al.
Publicado: (2020)

Diagnosing ventilator-associated pneumonia (VAP) in UK NHS ICUs: the perceived value and role of a novel optical technology
por: Jones, W. S., et al.
Publicado: (2022)

Duration of mechanical ventilation in trauma patients: risk factor for VAP?
por: Turriziani, I, et al.
Publicado: (2015)

Heat and moisture exchanger PALLBB22-15F can prevent ventilator-associated pneumonia (VAP) in short term mechanically ventilated ICU patients
por: Yassin, MY
Publicado: (1999)

Susceptibility to carbapenems of Pseudomonas spp. isolated from patients with ventilator-associated pneumonia
por: Zolotukhin, K, et al.
Publicado: (2006)

Bronchoalveolar lavage of ventilator‐associated pneumonia patients for antibiotic resistance and susceptibility test
por: Ahmadinejad, Mojtaba, et al.
Publicado: (2022)

Carbapenem-Resistant Klebsiella pneumoniae Among Patients with Ventilator-Associated Pneumonia: Evaluation of Antibiotic Combinations and Susceptibility to New Antibiotics
por: Ramadan, Raghdaa A, et al.
Publicado: (2022)

Mortality, incidence, and microbiological documentation of ventilated acquired pneumonia (VAP) in critically ill patients with COVID-19 or influenza
por: Laurichesse, Guillaume, et al.
Publicado: (2023)

Ventilator-associated pneumonia (VAP) caused by carbapenem-resistant Acinetobacter baumannii in patients with COVID-19: Two problems, one solution?
por: Lima, William Gustavo, et al.
Publicado: (2020)

Antibiotic and Disinfectant Susceptibility Patterns of Bacteria Isolated from Farmed Fish in Kirinyaga County, Kenya
por: Wanja, Daniel W., et al.
Publicado: (2020)

Comparison of the evolution of mechanical ventilation associated pneumonia (VAP) before the implantation of selective digestive decontamination (DDS) and after implantation of pneumonia zero program (NZ)
por: Fernández Fernández, R, et al.
Publicado: (2015)

Metagenomics for the microbiological diagnosis of hospital-acquired pneumonia and ventilator-associated pneumonia (HAP/VAP) in intensive care unit (ICU): a proof-of-concept study
por: Heitz, Morgane, et al.
Publicado: (2023)

A comparative study between effect of combined intravenous and nebulized amikacin versus intravenous amikacin alone in mechanically ventilated patients with ventilator-associated pneumonia (VAP)
por: El Fawy, Dalia M., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_ae58t6mqr8mtt6i677t9bk952m